An Act Concerning The Administration Of Vaccines To Children By Pharmacists.
Summary
HB 6581 would amend section 20-633 of the Connecticut General Statutes to allow pharmacists to administer vaccines to children regardless of age. Under current law, pharmacists’ authority to vaccinate children is limited by age; this bill would remove that age-based restriction and expand pharmacists’ role in pediatric immunization.
The measure is straightforward and narrowly focused on vaccine administration. It does not create a new vaccine requirement or change which vaccines are available; rather, it changes who may administer them and to whom, by broadening pharmacists’ authority to vaccinate minors of any age.
Impact
If enacted, the bill would directly modify state pharmacy and public health law by expanding the scope of practice for pharmacists under section 20-633. It would affect pharmacists, parents and guardians seeking convenient vaccination options, and children who could receive immunizations in pharmacy settings without age-based limits. The bill could also influence access to routine childhood vaccines and the distribution of vaccination services across healthcare providers.
Sentiment
No committee transcript or recorded vote information is available, so there is no documented debate or formal sentiment in the provided materials. Based on the bill text alone, the proposal appears practical and administrative in nature, aimed at increasing access to vaccines through pharmacies. Because the bill is narrowly drafted, the available record does not show clear support or opposition from legislators or stakeholders.
Contention
The main potential point of contention is whether pharmacists should be authorized to vaccinate very young children, including infants and toddlers, and whether pharmacies have the training, equipment, and clinical protocols needed for pediatric immunization. Supporters would likely emphasize convenience, access, and public health benefits, while opponents may raise concerns about safety, age-appropriate care, and whether pediatric vaccines should remain primarily within physician or pediatric practice settings.